Related Experiment Video
Updated: Oct 20, 2025

Using Real-Time Cell Metabolic Flux Analyzer to Monitor Osteoblast Bioenergetics
Published on: March 1, 2022
Endogenous Glucocorticoid Metabolism in Bone: Friend or Foe
Claire S Martin1, Mark S Cooper2, Rowan S Hardy3,4
1Institute of Metabolism and Systems Research, University of Birmingham, Birmingham, United Kingdom.
Abstract:
The role of tissue specific metabolism of endogenous glucocorticoids (GCs) in the pathogenesis of human disease has been a field of intense interest over the last 20 years, fuelling clinical trials of metabolism inhibitors in the treatment of an array of metabolic diseases. Localised pre-receptor metabolism of endogenous and therapeutic GCs by the 11β-hydroxysteroid dehydrogenase (11β-HSD) enzymes (which interconvert endogenous GCs between their inactive and active forms) are increasingly recognised as being critical in mediating both their positive and negative actions on bone homeostasis. In this review we explore the roles of endogenous and therapeutic GC metabolism by the 11β-HSD enzymes in the context of bone metabolism and bone cell function, and consider future strategies aimed at modulating this system in order to manage and treat various bone diseases.
Insights
Tissue-specific metabolism of glucocorticoids (GCs) by 11β-hydroxysteroid dehydrogenase (11β-HSD) enzymes critically impacts bone homeostasis. Modulating GC metabolism offers potential therapeutic strategies for bone diseases.
Area of Science:
- Endocrinology
- Metabolic Disease Research
- Bone Biology
Background:
- Glucocorticoids (GCs) play a vital role in human health and disease.
- Tissue-specific metabolism of GCs is crucial for their function.
- 11β-hydroxysteroid dehydrogenase (11β-HSD) enzymes regulate GC activity by interconverting active and inactive forms.
Purpose of the Study:
- To review the role of endogenous and therapeutic GC metabolism by 11β-HSD enzymes in bone homeostasis.
- To explore the impact of GC metabolism on bone cell function.
- To consider future therapeutic strategies targeting GC metabolism for bone diseases.
Main Methods:
- Literature review focusing on the role of 11β-HSD enzymes in GC metabolism.
- Analysis of studies investigating GC metabolism in the context of bone homeostasis and cell function.
- Synthesis of current knowledge and future directions in the field.
Main Results:
- Localised pre-receptor metabolism of GCs by 11β-HSD enzymes is critical for bone homeostasis.
- GC metabolism influences both positive and negative actions on bone.
- Dysregulation of GC metabolism is implicated in various bone diseases.
Conclusions:
- 11β-HSD enzymes are key regulators of GC action in bone.
- Targeting GC metabolism presents a promising therapeutic avenue for managing bone diseases.
- Further research into modulating GC metabolism could lead to novel treatments for metabolic and bone disorders.
Related Concept Videos
Hormones and Bone Tissue
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
Osteoclasts in Bone Remodeling
Hormones of the Adrenal Glands
The adrenal cortex, a powerhouse of hormone synthesis, generates over two dozen corticosteroid hormones. The zona glomerulosa produces mineralocorticoids, exemplified by aldosterone, influencing the electrolyte composition of body fluids. The synthesis of glucocorticoids such as cortisol and...
Bone Remodeling
Regulation of Metabolism
Bone Disorders
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...

